// App-Quantinova.ai

: Cost-effectiveness of fixed-dose combinations therapies for COPD in Spain

Researchers

Presenter

  • Margarita Capel

Principal Investigators

  • Maria Mareque

  • Carlos Jose Alvarez

  • Leandro Lindner

  • Itziar Oyagez

Medical Centers

  • AstraZeneca, Madrid, Spain

  • Pharmacoeconomics Outcomes Research Iberica, Madrid, Spain

  • Servicio de Hematologia, Hospital 12 de Octubre, Madrid, Spain

  • Astra Zeneca, Cambridge, United Kingdom

Locations

  • Spain

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • Tiotropium/olodaterol

  • LAS 34273

  • Olodaterol

  • BI-1744

  • Formoterol

  • Tiotropium bromide

Outcome

  • N/A

Study Design

  • Fixed Dose

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved